Special Issue "COVID-19 after One Year of Clinical Experience: Unexpected Clinical Presentations or Complications and Post-COVID-19 Clinical Features"
Deadline for manuscript submissions: 30 April 2022.
Interests: immunology; vascular medicine; cardiology; infectious disease; neurology; coagulation and clinical laboratory
Special Issues, Collections and Topics in MDPI journals
Special Issue in Journal of Clinical Medicine: Unusual Clinical Presentation of COVID-19
Special Issue in Medicina: Emergency Medicine and Emergency Room Medical Issues
Special Issue in Viruses: COVID-19 and Thrombosis
Special Issue in Life: The New Frontier of Venous Thromboembolism
Special Issue in Healthcare: Artificial Intelligence in the Management of the Pandemic
Special Issue in Cells: Antithrombotics from Pharmacological Effects to Clinical Evidences
Interests: pneumology; intensive care; rare disease; non invasive mechanical ventilation; invasive mechanical ventilation; weaning from tracheostomy; neuromuscular disorders
Nearly one year ago, the SARS-CoV-2 outbreak began, and our work has changed since. Scientific literature contributed to the knowledge of this virus and its related infectious diseases, with the number of submissions and articles around the world increasing exponentially as a result.
Each colleague contributed by sharing their working experience, and COVID-19 has thus been associated to a number of relevant clinical abnormalities per se and\or during treatment.
Immunopathological complication and thrombotic complications have been identified since the first reports from China, but the description of other complications such as liver and cardiac damages have also been associated to COVID-19.
On the other hand, since COVID-19 is a newly identified disease, little is known about post-COVID-19 clinical features that are an emerging cause of chronic disability for several patients.
Indeed, in recent months, evidence has emerged that in patients with microbiological healing from COVID-19, many residual symptoms persist. The persistence of respiratory, cardiovascular or metabolic disorders, due to persistent chronic inflammation, sequelae of organ damage, and complications from the prolonged hospitalization and social isolation results in post acute COVID-19 syndrome. Follow up is needed after COVID-19, with appropriate management of clinical sequelae.
Thus, the aim of this thematic series is to report unusual clinical presentations or complications of COVID-19 and post-COVID-19 clinical features. Scientific contributions may be submitted as original articles, reviews, or brief clinical series.
We look forward to reading about your clinical experience in the daily clinical management of COVID-19 from diagnostics to therapeutic aspects.
Dr. Pierpaolo Di Micco
Dr. Anna Annunziata
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immunopathological disease
- venous thromboembolism